Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 28, 2015; 21(36): 10443-10452
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10443
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10443
Table 2 Overall curative effect based on mRECIST criteria n
Chemoembolizationgroup (n = 39) | Chemoembolization + HAICgroup (n = 45) | P-value | |
CR | 5 | 12 | |
PR | 12 | 19 | |
SD | 9 | 8 | |
PD | 11 | 6 | |
Not evaluated | 2 (lost) | 0 | |
ORR | 17/37 (45.9%) | 31/45 (68.9%) | 0.036 |
DCR | 26/37 (70.3%) | 39/45 (86.7%) | 0.068 |
-
Citation: Gao S, Zhang PJ, Guo JH, Chen H, Xu HF, Liu P, Yang RJ, Zhu X. Chemoembolization alone
vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients. World J Gastroenterol 2015; 21(36): 10443-10452 - URL: https://www.wjgnet.com/1007-9327/full/v21/i36/10443.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i36.10443